Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

被引:7
作者
Alkhouri, Naim [1 ]
Carter-Kent, Christine [1 ]
Feldstein, Ariel E. [1 ,2 ,3 ]
机构
[1] Cleveland Clin, Dept Pediat Gastroenterol, Cleveland, OH 44195 USA
[2] Cleveland Clin, Coll Med CWRU, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA
关键词
apoptosis; caspase inhibitor; cell death; cytokeratin; 18; fibrosis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; ENDOPLASMIC-RETICULUM STRESS; TUMOR-NECROSIS-FACTOR; MEDIATED HEPATOCYTE APOPTOSIS; ATTENUATES HEPATIC-INJURY; CATHEPSIN-B CONTRIBUTES; CYTOCHROME-C RELEASE; CASPASE INHIBITOR; TNF-ALPHA; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE;
D O I
10.1586/EGH.11.6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pathological increases in cell death in the liver as well as in peripheral tissues has emerged as an important mechanism involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). An increase in hepatocyte cell death by apoptosis is typically present in patients with NAFLD and in experimental models of steatohepatitis, while an increase in adipocyte cell death in visceral adipose tissue may be an important mechanism triggering insulin resistance and hepatic steatosis. The two fundamental pathways of apoptosis, the extrinsic (death receptor-mediated) and intrinsic (organelle-initiated) pathways, are both involved. This article summarizes the current knowledge related to the distinct molecular and biochemical pathways of cell death involved in NAFLD pathogenesis. In particular, it will highlight the efforts for the development of both novel diagnostic and therapeutic strategies based on this knowledge.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 124 条
[1]   A pilot trial of pentoxifylline in nonalcoholic steatohepatitis [J].
Adams, LA ;
Zein, CO ;
Angulo, P ;
Lindor, KD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2365-2368
[2]   Death receptor-mediated liver injury [J].
Akazawa, Yuko ;
Gores, Gregory J. .
SEMINARS IN LIVER DISEASE, 2007, 27 (04) :327-338
[3]  
Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32
[4]   Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis [J].
Alkhouri, Naim ;
Gornicka, Agnieszka ;
Berk, Michael P. ;
Thapaliya, Samjhana ;
Dixon, Laura J. ;
Kashyap, Sangeeta ;
Schauer, Philip R. ;
Feldstein, Ariel E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (05) :3428-3438
[5]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[6]   Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis [J].
Anstee, Quentin M. ;
Concas, Danilo ;
Kudo, Hiromi ;
Levene, Adam ;
Pollard, John ;
Charlton, Peter ;
Thomas, Howard C. ;
Thursz, Mark R. ;
Goldin, Robert D. .
JOURNAL OF HEPATOLOGY, 2010, 53 (03) :542-550
[7]   Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells [J].
Antonsson, B ;
Montessuit, S ;
Sanchez, B ;
Martinou, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11615-11623
[8]   A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients [J].
Anty, R. ;
Iannelli, A. ;
Patouraux, S. ;
Bonnafous, S. ;
Lavallard, V. J. ;
Senni-Buratti, M. ;
Ben Amor, I. ;
Staccini-Myx, A. ;
Saint-Paul, M. -C. ;
Berthier, F. ;
Huet, P. -M. ;
Le Marchand-Brustel, Y. ;
Gugenheim, J. ;
Gual, P. ;
Tran, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (11-12) :1315-1322
[9]   PF-03491390 PAN-CASPASE INHIBITOR DECREASES LIVER INJURY AND FIBROSIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) [J].
Barreyro, F. J. ;
Holod, S. ;
Finocchietto, P. V. ;
Avagnina, A. ;
Camino, A. M. ;
Biondo, C. M. ;
Aquino, J. B. ;
Carreras, M. C. ;
Poderoso, J. J. ;
Gores, G. J. .
JOURNAL OF HEPATOLOGY, 2010, 52 :S303-S303
[10]   Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis [J].
Barreyro, Fernando J. ;
Kobayashi, Shogo ;
Bronk, Steven F. ;
Werneburg, Nathan W. ;
Malhi, Harmeet ;
Gores, Gregory J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) :27141-27154